Torrent Pharmaceuticals
Quarterly Results Analysis [Jun2022]
Torrent Pharmaceuticals Quarterly Results
Consolidated | Jun2022 UnAudited |
Mar2022 Audited |
Dec2021 UnAudited |
Sep2021 UnAudited |
Jun2021 Audited |
Mar2021 Audited |
Dec2020 UnAudited |
Sep2020 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹2,347 Cr | ₹2,131 Cr | ₹2,108 Cr | ₹2,137 Cr | ₹2,134 Cr | ₹1,937 Cr | ₹1,995 Cr | ₹2,017 Cr |
Expenses | ₹1,635 Cr | ₹1,570 Cr | ₹1,570 Cr | ₹1,477 Cr | ₹1,457 Cr | ₹1,355 Cr | ₹1,388 Cr | ₹1,382 Cr |
Operating Income | ₹712 Cr | ₹561 Cr | ₹538 Cr | ₹660 Cr | ₹677 Cr | ₹582 Cr | ₹607 Cr | ₹635 Cr |
Other Income | ₹30 Cr | ₹56 Cr | ₹48 Cr | ₹51 Cr | ₹40 Cr | ₹39 Cr | ₹8 Cr | ₹6 Cr |
Interest | ₹55 Cr | ₹57 Cr | ₹62 Cr | ₹71 Cr | ₹68 Cr | ₹73 Cr | ₹91 Cr | ₹92 Cr |
Depreciation | ₹155 Cr | ₹162 Cr | ₹167 Cr | ₹168 Cr | ₹165 Cr | ₹165 Cr | ₹167 Cr | ₹165 Cr |
Profit Before Tax | ₹532 Cr | ₹-87 Cr | ₹357 Cr | ₹472 Cr | ₹484 Cr | ₹383 Cr | ₹357 Cr | ₹384 Cr |
Profit After Tax | ₹354 Cr | ₹-118 Cr | ₹249 Cr | ₹316 Cr | ₹330 Cr | ₹324 Cr | ₹297 Cr | ₹310 Cr |
EPS | ₹10.46 | ₹-3.49 | ₹7.36 | ₹9.34 | ₹9.75 | ₹9.57 | ₹8.77 | ₹9.16 |
Industry Peers & Returns | 1W | 1M | 1Y |
Torrent Pharmaceuticals | -1.1% | 3.5% | 1.4% |
SUN PHARMACEUTICAL INDUSTRIES | -0.2% | 6.2% | 16% |
DIVIS LABORATORIES | -4.7% | -1.3% | -19.7% |
DR REDDYS LABORATORIES | 2.6% | -5.4% | -11% |
CIPLA | -0.7% | 7.8% | 13.8% |
GLAND PHARMA | 4.5% | -3.4% | -44.2% |
PIRAMAL ENTERPRISES | 11.2% | 13.1% | -31.4% |
CADILA HEALTHCARE | 8.3% | 5.1% | -33.9% |
ALKEM LABORATORIES | -4.9% | -5.7% | -16.6% |
Torrent Pharmaceuticals Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 10.14 % |
Y-o-Y | 9.98 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2022 | ₹2,347 Cr | 10.14 | |
Mar2022 | ₹2,131 Cr | 1.09 | |
Dec2021 | ₹2,108 Cr | -1.36 | |
Sep2021 | ₹2,137 Cr | 0.14 | |
Jun2021 | ₹2,134 Cr | 10.17 | |
Mar2021 | ₹1,937 Cr | -2.91 | |
Dec2020 | ₹1,995 Cr | -1.09 | |
Sep2020 | ₹2,017 Cr | - |
Torrent Pharmaceuticals Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 26.92 % |
Y-o-Y | 5.17 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2022 | ₹712 Cr | 26.92 | |
Mar2022 | ₹561 Cr | 4.28 | |
Dec2021 | ₹538 Cr | -18.48 | |
Sep2021 | ₹660 Cr | -2.51 | |
Jun2021 | ₹677 Cr | 16.32 | |
Mar2021 | ₹582 Cr | -4.12 | |
Dec2020 | ₹607 Cr | -4.41 | |
Sep2020 | ₹635 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 15.23 % |
Y-o-Y | -4.35 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2022 | 30.34% | 15.23 | |
Mar2022 | 26.33% | 3.17 | |
Dec2021 | 25.52% | -17.36 | |
Sep2021 | 30.88% | -2.65 | |
Jun2021 | 31.72% | 5.56 | |
Mar2021 | 30.05% | -1.25 | |
Dec2020 | 30.43% | -3.34 | |
Sep2020 | 31.48% | - |
Torrent Pharmaceuticals Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Positive |
Y-o-Y | 7.27 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2022 | ₹354 Cr | Positive | |
Mar2022 | ₹-118 Cr | Negative | |
Dec2021 | ₹249 Cr | -21.20 | |
Sep2021 | ₹316 Cr | -4.24 | |
Jun2021 | ₹330 Cr | 1.85 | |
Mar2021 | ₹324 Cr | 9.09 | |
Dec2020 | ₹297 Cr | -4.19 | |
Sep2020 | ₹310 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Positive |
Y-o-Y | -2.46 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2022 | 15.08 % | Positive | |
Mar2022 | -5.54 % | Negative | |
Dec2021 | 11.81 % | -20.15 | |
Sep2021 | 14.79 % | -4.33 | |
Jun2021 | 15.46 % | -7.59 | |
Mar2021 | 16.73 % | 12.36 | |
Dec2020 | 14.89 % | -3.12 | |
Sep2020 | 15.37 % | - |
Torrent Pharmaceuticals Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Positive |
Y-o-Y | 7.28 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2022 | ₹10.46 | Positive | |
Mar2022 | ₹-3.49 | Negative | |
Dec2021 | ₹7.36 | -21.20 | |
Sep2021 | ₹9.34 | -4.21 | |
Jun2021 | ₹9.75 | 1.88 | |
Mar2021 | ₹9.57 | 9.12 | |
Dec2020 | ₹8.77 | -4.26 | |
Sep2020 | ₹9.16 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
